Scales for Measuring Parkinsonism in Demented Patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Springer US

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4471-6365-7_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychosis in Alzheimer's disease.

  2014cited by this paper
• Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

  2013cited by this paper
• Assessing Bradykinesia in Parkinsonian Disorders

  2013cited by this paper
• Extrapyramidal Signs by Dementia Severity in Alzheimer Disease and Dementia With Lewy Bodies

  2013cited by this paper
• β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia

  2013cited by this paper
• A Rating Scale for Gait Evaluation in Cognitive Deterioration (RSGE-CD): Validation Study

  2012cited by this paper
• The Unified Multiple System Atrophy Rating Scale: Intrarater reliability

  2012cited by this paper
• Symptoms and Quality of Life in Late Stage Parkinson Syndromes: A Longitudinal Community Study of Predictive Factors

  2012cited by this paper
• Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.

  2012cited by this paper
• Treatment of multiple system atrophy using intravenous immunoglobulin

  2012cited by this paper
• Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

  2012cited by this paper
• Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

  2012cited by this paper
• Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE

  2011cited by this paper
• Voxel‐Based Analysis of Diffusion Tensor Imaging in Patients with Subcortical Vascular Cognitive Impairment: Correlates with Cognitive and Motor Deficits

  2011cited by this paper
• Pyramidal and extrapyramidal scale (PEPS): a new scale for the assessment of motor impairment in vascular cognitive impairment associated with small vessel disease.

  2011cited by this paper
• Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.

  2011cited by this paper
• Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

  2011cited by this paper
• Teaching program for the movement disorder society‐sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS‐UPDRS)

  2010cited by this paper
• Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population‐based study of elders

  2010cited by this paper
• Systematic Evaluation of Rating Scales for Drug-Induced Parkinsonism and Recommendations for Future Research

  2010cited by this paper
• Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology

  2009cited by this paper
• The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

  2008cited by this paper
• Dementia and survival in Parkinson disease

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan

  2007cited by this paper
• The effect of age of onset of PD on risk of dementia

  2007cited by this paper
• A clinical rating scale for progressive supranuclear palsy.

  2007cited by this paper
• Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease

  2006cited by this paper
• More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction.

  2006cited by this paper
• Changes in motor subtype and risk for incident dementia in Parkinson's disease

  2006cited by this paper
• Bmc Medical Research Methodology Open Access Motor Function in Parkinson's Disease and Supranuclear Palsy: Simultaneous Factor Analysis of a Clinical Scale in Several Populations

  2006cited by this paper
• Association of daytime napping and Parkinsonian signs in Alzheimer's disease.

  2006cited by this paper
• Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision

  2006cited by this paper
• Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies

  2006cited by this paper
• Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG)

  2006cited by this paper
• The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey

  2005cited by this paper
• A systematic review of prevalence studies of dementia in Parkinson's disease

  2005cited by this paper
• Progression of parkinsonism in multiple system atrophy

  2005cited by this paper
• Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

  2005cited by this paper
• The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.

  2005cited by this paper
• The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

  2004cited by this paper
• Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

  2004cited by this paper
• A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA

  2004cited by this paper
• Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

  2003cited by this paper
• Neuromotor abnormalities and risk for psychosis in Alzheimer’s disease

  2003cited by this paper
• Cholinesterase inhibitors for dementia with Lewy bodies.

  2003cited by this paper
• Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease

  2002cited by this paper
• Application of the International Cooperative Ataxia Scale rating in multiple system atrophy

  2002cited by this paper
• Systematic evaluation of rating scales for impairment and disability in Parkinson's disease

  2002cited by this paper
• Committee. Unified Parkinson’s Disease Rating Scale.

  2001cited by this paper
• Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.

  2001cited by this paper
• Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale

  2000cited by this paper
• A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease

  2000cited by this paper
• Progression of parkinsonian signs in Alzheimer’s disease

  2000cited by this paper
• Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group.

  1999cited by this paper
• Extrapyramidal Motor Signs in Clinically Diagnosed Alzheimer Disease

  1996cited by this paper
• Neuropathologic and neurochemical correlates of psychosis in primary dementia.

  1991cited by this paper
• Age‐induced cognitive disturbances in Parkinson's disease

  1990cited by this paper
• The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset.

  1989cited by this paper
• Functional assessment staging (FAST).

  1988cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• Heterogeneity in dementia of the Alzheimer type

  1985cited by this paper
• Treatment of parkinsonism with levodopa.

  1969cited by this paper
• Critical analysis of the disability in Parkinson's disease.

  1968cited by this paper
• Parkinsonism

  1967cited by this paper

• Rating Scales in Movement Disorders

  2017cites this paper